Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression

Frontiers Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer

Cells, Free Full-Text

Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial

Current Treatment Landscape and Emerging Therapies for Metastatic Triple-Negative Breast Cancer

Cancers, Free Full-Text

PDF) Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

Cells, Free Full-Text

Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer - ScienceDirect

Cancers, Free Full-Text

Cancers, Free Full-Text

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression

PDF] Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

Long Non-Coding RNAs in Triple-Negative Breast Cancer

Triple-negative breast cancer: understanding Wnt signaling in drug resistance, Cancer Cell International